Recombinant Escherichia coli O139:H28 Cardiolipin synthase (cls)

What is cardiolipin synthase and what is its function in bacterial cells?

Cardiolipin synthase (cls) is an essential enzyme responsible for synthesizing cardiolipin, a large anionic glycerol phospholipid composed of four acyl chains connected by a small glycerol head group. This conical-shaped phospholipid accumulates at membrane regions with negative curvature. In Enterobacteriaceae, cardiolipin is synthesized within the inner membrane primarily by the ClsA enzyme, with ClsB and ClsC providing supplementary synthesis capacity .

The main function of cardiolipin synthase is to catalyze the formation of cardiolipin through one of two mechanisms: either by condensing two phosphatidylglycerol (PG) molecules (as performed by ClsA and ClsB) or by condensing phosphatidylglycerol and phosphatidylethanolamine (PE) molecules (as performed by ClsC) . The specific E. coli O139:H28 CardioLipin Synthase is a full-length protein (486 amino acids) that has been characterized and produced as a recombinant protein for research applications .

How do different cardiolipin synthases in E. coli differ in their expression patterns and activity?

E. coli possesses three distinct cardiolipin synthases: ClsA, ClsB, and ClsC, each with unique expression patterns and activities:

• ClsA (encoded by cls/clsA): Serves as the major cardiolipin synthase during exponential growth phase. Deletion of clsA results in almost complete loss of detectable cardiolipin (from approximately 7% in wild-type to undetectable levels) and a corresponding increase in phosphatidylglycerol .

• ClsB (encoded by ybhO): Shows minimal contribution during exponential growth. Deletion of clsB has negligible effect on cardiolipin levels under standard growth conditions .

• ClsC (encoded by ymdC): Becomes significantly active during stationary phase. Evidence shows that clsC contributes to cardiolipin synthesis during stationary phase, as a clsA mutant shows approximately 1% cardiolipin in stationary phase, but a clsA clsC double mutant completely lacks cardiolipin .

During intracellular growth conditions, expression levels of clsB and clsC can be induced approximately 10-fold, suggesting environmental regulation of cardiolipin synthesis .

What experimental approaches can quantify cardiolipin levels in bacterial membranes?

Researchers can employ several methodological approaches to quantify cardiolipin levels:

• Bligh-Dyer Phospholipid Isolation: This liquid-liquid extraction method effectively separates phospholipids from bacterial membranes. The protocol uses chloroform, methanol, and water to create phase separation that isolates lipids from cellular components .

• Thin-Layer Chromatography (TLC): Following extraction, phospholipids can be separated and visualized using TLC. This technique allows for relative quantification of different phospholipids, including cardiolipin, phosphatidylglycerol, and phosphatidylethanolamine .

• Membrane Fractionation: To analyze the distribution of cardiolipin between inner and outer membranes, researchers can use Sarkosyl solubilization to fractionate the membranes before applying the extraction and separation techniques. Verification of proper membrane separation should be performed using Western blotting for membrane-specific marker proteins (e.g., SecA for inner membrane and OmpA for outer membrane) .

These methods typically show that cardiolipin constitutes approximately 7% of total phospholipids during exponential growth phase and increases to about 10% during stationary phase in wild-type E. coli .

What expression systems are optimal for producing recombinant E. coli O139:H28 cardiolipin synthase?

For optimal recombinant production of E. coli O139:H28 cardiolipin synthase:

• Expression System: The most effective expression system is E. coli itself, which provides the appropriate cellular machinery for proper folding of this membrane-associated enzyme. Commercial recombinant Cardiolipin synthase proteins are produced using E. coli expression systems .

• Tagging Strategy: N-terminal His-tagging has proven successful for purification purposes without compromising enzymatic function. The full-length protein (amino acids 1-486) with an N-terminal His-tag maintains its structural integrity and function .

• Expression Conditions: While specific optimization parameters depend on the expression vector and strain used, general recommendations include:

  • Induction at mid-log phase (OD600 ~0.6-0.8)

  • Lower induction temperatures (16-25°C) to enhance proper folding

  • Extended expression periods (overnight) at reduced temperatures

  • Careful cell lysis methods to preserve membrane protein integrity

What purification strategies yield functional cardiolipin synthase protein?

To obtain functional recombinant cardiolipin synthase:

• Initial Capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin effectively captures His-tagged cardiolipin synthase. Gentle detergents must be incorporated in all buffers to maintain protein solubility.

• Buffer Composition: Recommended storage buffer includes Tris/PBS-based buffer at pH 8.0 with 6% trehalose as a stabilizing agent .

• Storage Conditions: The purified protein should be stored as lyophilized powder or in solution with 5-50% glycerol (with 50% being optimal) at -20°C/-80°C. Repeated freeze-thaw cycles should be avoided to maintain enzyme activity .

• Reconstitution Protocol: For experimental use, reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL .

How does cardiolipin contribute to bacterial membrane organization and function?

Cardiolipin plays several critical roles in bacterial membrane organization:

• Membrane Curvature: Due to its conical shape (four large acyl chains connected by a small glycerol head group), cardiolipin naturally accumulates at membrane regions with negative curvature. This property makes it essential for maintaining proper membrane architecture, particularly at bacterial poles .

• Protein Localization: Cardiolipin facilitates the proper localization of various membrane proteins. In pathogens like Shigella flexneri, cardiolipin in the outer membrane is crucial for proper presentation of virulence proteins such as IcsA on the bacterial surface .

• Electron Transport: Similar to its role in mitochondria, cardiolipin influences both the localization and activity of electron transport proteins in the bacterial inner membrane .

• Membrane Domain Formation: Cardiolipin contributes to the formation of specialized membrane domains, particularly at the poles of bacterial cells, which affects numerous cellular processes including division and protein sorting .

What is the relationship between cardiolipin synthesis and bacterial cell division?

Cardiolipin synthesis is intimately connected to bacterial cell division through several mechanisms:

• Division Site Localization: Cardiolipin localizes to the poles and division septa in bacterial cells, where it helps recruit and stabilize division proteins .

• Filamentation in Deficient Strains: When cardiolipin synthesis is disrupted (e.g., in clsA mutants), bacteria can develop filamentous morphology during intracellular growth, indicating impaired cell division. This has been directly observed using time-lapse confocal microscopy of fluorescently labeled bacteria in host cells .

• Intracellular Growth: Research using S. flexneri as a model shows that while clsA mutants initially grow normally inside host cells, they eventually form filaments after several rounds of replication, suggesting a progressive defect in the division process .

• Protein Functionality: Cardiolipin affects the localization and activity of proteins required for cell division, creating a direct link between phospholipid composition and the division machinery .

The specific mechanisms connecting cardiolipin to division proteins involve both direct binding interactions and indirect effects through membrane curvature and fluidity.

How does cardiolipin transport to the outer membrane affect bacterial pathogenesis?

The transport of cardiolipin from the inner to the outer membrane significantly impacts bacterial pathogenesis through several mechanisms:

• Protein Transport System: In Enterobacteriaceae, cardiolipin is transported from the inner to the outer membrane by PbgA (also known as YejM), a dedicated phospholipid transporter .

• Virulence Protein Localization: Cardiolipin in the outer membrane facilitates proper presentation of virulence factors. In S. flexneri, cardiolipin is essential for proper localization of the actin polymerization protein IcsA on the bacterial surface, which is critical for cell-to-cell spread during infection .

• Plaque Formation: Experimental evidence shows that both clsA (cardiolipin synthesis) and pbgA (cardiolipin transport) mutants have severe defects in plaque formation in cell culture models, indicating impaired cell-to-cell spread .

• Differential Effects: Interestingly, while both mutants have defects in pathogenesis, they act at different points in the virulence pathway. The pbgA mutant fails to properly localize IcsA to the bacterial surface, preventing cell-to-cell spread, whereas the clsA mutant shows partial IcsA localization but later develops division defects .

These findings establish a dual function for cardiolipin in bacterial pathogenesis: in the inner membrane, it supports proper cell division during intracellular growth, while in the outer membrane, it enables the presentation of virulence factors required for pathogen dissemination .

What are the functional domains and structural features of cardiolipin synthase?

While the search results don't provide direct information on the specific functional domains of E. coli O139:H28 cardiolipin synthase, inference from related research suggests that this enzyme contains:

• Transmembrane Domains: The N-terminal region contains multiple transmembrane helices that anchor the protein in the bacterial inner membrane. The presence of these domains is supported by the hydrophobic nature of portions of the amino acid sequence .

• Catalytic Domain: The enzyme contains a catalytic domain responsible for the condensation reaction between phospholipid substrates. In ClsA, this domain catalyzes the reaction between two phosphatidylglycerol molecules to form cardiolipin .

• Substrate Recognition Sites: The enzyme must contain binding pockets for its phospholipid substrates, with specificity that differentiates between phosphatidylglycerol and other phospholipids.

The structure of cardiolipin synthase enables its localization to the bacterial inner membrane, where it can access its phospholipid substrates and contribute to membrane phospholipid composition.

How can recombinant cardiolipin synthase be used in synthetic biology applications?

Recombinant cardiolipin synthase offers several applications in synthetic biology:

• Membrane Engineering: By expressing recombinant cardiolipin synthase in bacterial strains, researchers can modify membrane composition to alter properties such as permeability, fluidity, and curvature. This approach enables the creation of bacteria with customized membrane characteristics for various applications .

• Biocontainment Strategies: Engineered dependency on cardiolipin synthase activity could be used to develop biocontainment strategies for genetically modified organisms, as disruption of cardiolipin synthesis leads to growth defects .

• Biosensors Development: The localization properties of cardiolipin can be exploited to develop biosensors for detecting changes in membrane organization or bacterial cellular state.

• Metabolic Engineering Platforms: Modification of membrane composition through cardiolipin synthase expression can create more robust bacterial strains for the production of biofuels, chemicals, or pharmaceuticals by enhancing tolerance to toxic products or process conditions.

What experimental approaches can distinguish the functions of different cardiolipin synthases in vivo?

To distinguish the functions of different cardiolipin synthases in vivo:

• Gene Deletion Analysis: Constructing single, double, and triple deletion mutants of clsA, clsB, and clsC allows researchers to determine the contribution of each enzyme to total cardiolipin synthesis under different growth conditions. Analysis showed that clsA is the major contributor during exponential growth, while clsC contributes during stationary phase .

• Growth Phase-Specific Analysis: By examining phospholipid composition at different growth phases (exponential vs. stationary), researchers can identify temporal patterns in cardiolipin synthase activity. This approach revealed that ClsC becomes active specifically during stationary phase .

• Environmental Response Studies: Examining gene expression and cardiolipin levels under various environmental conditions (pH, osmolarity, temperature) can reveal condition-specific roles for each cardiolipin synthase.

• Intracellular Infection Models: Using bacterial pathogens in cellular infection models allows the examination of cardiolipin synthase expression and function during host-pathogen interactions. Studies with S. flexneri revealed 10-fold induction of clsB and clsC during intracellular growth .

• Fluorescent Tagging: Employing fluorescently tagged cardiolipin-binding probes in combination with confocal microscopy enables visualization of cardiolipin distribution in bacterial membranes and can reveal functional differences between synthases.

What are the current challenges in studying cardiolipin synthase function?

Several significant challenges persist in studying cardiolipin synthase function:

• Functional Redundancy: The presence of multiple cardiolipin synthases (ClsA, ClsB, ClsC) with partially overlapping functions complicates the analysis of individual enzyme contributions .

• Compensation by Other Phospholipids: When cardiolipin synthesis is impaired, other anionic phospholipids like phosphatidylglycerol can partially compensate for its absence, making it difficult to isolate specific cardiolipin-dependent phenotypes. For instance, in clsA mutants, increased phosphatidylglycerol in the outer membrane partially compensates for the loss of cardiolipin .

• Membrane Protein Challenges: As an integral membrane protein, cardiolipin synthase presents technical challenges for structural studies, purification, and reconstitution in active form.

• Environmental Variability: The activity and expression of cardiolipin synthases vary significantly based on growth conditions, growth phase, and environmental stressors, requiring controlled experimental conditions for consistent results .

• Integration with Other Membrane Components: Cardiolipin functions as part of a complex membrane environment, making it difficult to distinguish direct effects of cardiolipin from indirect effects through interactions with other membrane components.